Sionna Therapeutics (SION) Accounts Payables (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Accounts Payables data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 57.98% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 57.98% YoY), and the FY2025 full-year result was $769000.0, down 35.16% from the prior year.
• Accounts Payables advanced to $2.1 million in Q1 2026, from $769000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $5.0 million in Q1 2025 to a low of $769000.0 in Q4 2025.
• A 3-year average of $1.9 million and a median of $1.3 million in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 35.16% in 2025 and tumbled 57.98% in 2026, its largest moves.
• Tracing SION's Accounts Payables over 3 years: stood at $1.2 million in 2024, then tumbled by 35.16% to $769000.0 in 2025, then surged by 174.25% to $2.1 million in 2026.
• Business Quant data shows SION's Accounts Payables at $2.1 million in Q1 2026, $769000.0 in Q4 2025, and $1.5 million in Q3 2025.